Resources

New vaccines targeting viruses linked with type 1 diabetes may offer protection to patients with high-risk factors.

The association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events. 

Behavioral changes during the pandemic can improve blood glucose control.

Tirzepatide is both a GIP and GLP-1 receptor agonist. 

By Sheri Colberg, PhD
Ever since the US Diabetes Prevention Program (DPP) multicenter trial was completed nearly two decades ago, we have known that it is possible to prevent, or at least delay, prediabetes (an insulin-resistant state) from progressing into full-blown type 2 diabetes.

Results of an extensive retrospective study indicate a strong association between glomerular filtration (eGFR) rate and cardiovascular disease morbidity rate.

Recently a patient presented to our outpatient diabetes education center. His A1C had historically been elevated, despite the initiation of insulin therapy and increasing doses. The patient reported that he had taken all insulin doses as ordered, but was frustrated with his lack of progress....

Better understanding of how certain viral infections may increase the incidence of type 1 diabetes could lead to new strategies for prevention. 

Studies are showing that intermittent fasting may help patients better manage their diabetes and reduce their insulin intake.

What do the new ADA guidelines have to say about treating children and adolescents with type 1 diabetes?